लोड हो रहा है...

Acquired Hemophilia A Successfully Treated with Rituximab

Acquired hemophilia A (AHA) is a rare bleeding disorder due to the development of specific autoantibodies against factor VIII. The anti-CD20 monoclonal antibody Rituximab has been proven to be effective in obtaining a long-term suppression of inhibitors of AHA, besides other immunosuppressive standa...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mediterr J Hematol Infect Dis
मुख्य लेखकों: D’Arena, Giovanni, Grandone, Elvira, Di Minno, Matteo Nicola Dario, Musto, Pellegrino, Di Minno, Giovanni
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Università Cattolica del Sacro Cuore 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4344169/
https://ncbi.nlm.nih.gov/pubmed/25745551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2015.024
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!